The efficacy of eight routine enteric agars for supporting the growth of 32 strains of Aeromonas spp. (17 A. hydrophila strains, 8 A. sobria strains, and 7 A. caviae strains) was investigated. The plating efficiency of Aeromonas spp. on these media varied greatly (range, 0 to 100%), as did their colony size when compared with that on noninhibitory medium (5% sheep blood agar). Plating efficiency on seven of these eight media appeared to be strain-and not species dependent. Overall, eosin-methylene blue and Hektoen enteric agars showed low plating efficiencies for A. hydrophila, whereas both A. sobria and A. caviae were severely inhibited on brilliant green agar. When all these species are considered collectively, deoxycholate, MacConkey, and xylose lysine deoxycholate appeared to be the most satisfactory routine agars for Aeromonas spp. recovery when used in conjunction with blood agar.
conjunction with blood agar.
Aeromonas species are increasingly being recognized as an important cause of gastroenteritis worldwide, and it has recently been suggested that they are also a cause of traveler's diarrhea (5, 6, 9) . Evidence supporting these aquatic bacteria as important gastrointestinal enteric pathogens includes well-described case studies (1, 3, 4, 13, 14) , a large case-controlled survey (5) , the demonstration of enterotoxin-producing strains (2) , serologic responses subsequent to gastrointestinal infection (3, 13) , and resolution of symptomatology subsequent to antimicrobial therapy directed against Aeromonas spp. (1, 4, 13) .
Although Aeromonas species are generally accepted as a cause of bacterial gastroenteritis, the actual incidence of this disease as well as colonization rates in humans may vary widely with geographic locale. Although a number of selective agars or enrichment broths have been devised for the recovery of these organisms (17) (16) and then identified to the species level as previously described (8, 11) .
Brilliant green (BG), bismuth sulfite (BS), deoxycholate (DC), Hektoen enteric (HE), salmonella-shigella (SS), and blood agar (BA) base (heart infusion agar) agars were obtained from Difco Laboratories, Detroit, Mich. MacConkey (MAC) agar was obtained from GIBCO Diagnostics, Madison, Wis., and xylose lysine DC (XLD) and Levine's eosin-methylene blue (EMB) agars were obtained from BBL Microbiology Systems, Cockeysville, Md. BA plates contained 5% sheep blood. All of the enteric agars and the BA plates were prepared in the microbiology laboratory, Bronx Veterans Administration Medical Center.
Measuring plating efficiency. A method similar to that described by Marold et al. (12) 
